Pfizer

Open: 30.46 Close: 30.73 Change: 0.27

Is Pfizer Company Inc a good investment? This what an AI found.

The game is changing. There is a new strategy to evaluate Pfizer fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, vaccine, say, price, Moderna, announce, Wednesday, and the …

Concept Map

Semantic Network

Stock Summary

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. Pfizer offers medicines and vaccines in various therapeutic areas. The company also provides biosimilars for chronic immune and inflammatory diseases.

Today's Summary

Pfizer announced Wednesday it would more than double the price of a lifesaving Covid-19 treatment. Consumer watchdog Public Citizen excoriated Pfizer after the pharmaceutical giant announced the price.

Today's News

Updated COVID-19 vaccine s from Pfizer, Moderna, or Novavax are rolling out this fall. Pfizers Penbraya is the first shot to protect against five groups of a deadly bacteria. Pfizer said patients may be more susceptible to infections in the five weeks after starting Velsipity (etrasimod) The drug belongs to a class of small molecule therapies that target the inflammatory responses that spur ulcerative colitis. Pfizer announced Wednesday it would more than double the price of a lifesaving Covid-19 treatment. Pfizer said Wednesday that it will price its patented Covid treatment nirmatrelvirvir-ritonavir at $1,390 for a five-day course. Consumer watchdog Public Citizen excoriated Pfizer after the pharmaceutical giant announced the price. The list price, before insurance, will be $1,390 for a five-day course, Pfizer said in a statement. The U.S. Food and Drug Administration is considering ordering a recipe change for vaccines. Pfizer does not expect commercialized doses to be widely used in 2023, as doses marked under the Emergency Use Authorization from the Food and Drug Administration will still be available for free until the end of the year. Pfizer and Moderna have said they are pricing each vaccine dose at over $100, NBC News previously reported. FDA authorized two new mRNA vaccines from Moderna and Pfizer-BioNTech.

Stock Profile

"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York."

Keywords

Are looking for the most relevant information about Pfizer? Investor spend a lot of time searching for information to make investment decisions in Pfizer. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, vaccine, say, price, Moderna, announce, Wednesday, and the most common words in the summary are: pfizer, vaccine, health, news, drug, covid19, bloomberg, . One of the sentences in the summary was: Consumer watchdog Public Citizen excoriated Pfizer after the pharmaceutical giant announced the price.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pfizer #vaccine #health #news #drug #covid19 #bloomberg.